Raghu Vikram K, Beaumont Jennifer L, Everly Matthew J, Venick Robert S, Lacaille Florence, Mazariegos George V
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Terasaki Research Institute, Los Angeles, California.
Pediatr Transplant. 2019 Dec;23(8):e13580. doi: 10.1111/petr.13580. Epub 2019 Sep 18.
The ITR serves as an international database for centers around the world to contribute to current knowledge about intestinal transplant outcomes. Led by the IRTA and managed by the Terasaki Research Institute, the ITR collects data annually and uses these data to generate reports that guide management strategies and policy statements. The aim of this manuscript was to analyze outcomes specific to pediatric intestinal transplantation. Outcome data for children transplanted from 1985 to 2017 were analyzed and predictive factors assessed. A total of 2010 children received 2080 intestine containing allografts during this period. Overall, 1-year and 5-year patient and graft survival were 72.7%/66.1% and 57.2/48.8%, respectively. One-year conditional survival was most strongly associated with being a first-time transplant recipient and liver-inclusive grafts. Patient survival was most strongly associated with elective status of transplantation as compared with hospitalized status. Enteral autonomy following transplantation has continued to improve by era with colonic inclusion demonstrating additional incremental improvement in enteral autonomy and freedom from intravenous fluid. While PTLD and technical complications contribute less to graft loss than in earlier eras, rejection remains the largest contributor to long-term graft loss. Re-transplantation is linked with significantly worse conditional graft survival, and sepsis remains the largest contributor to patient death. Newer data elements are focusing on impact of donor variables, donor and recipient tissue typing, and impact of the development of de novo antibodies.
国际肠道移植登记处(ITR)是一个国际数据库,供世界各地的中心贡献有关肠道移植结果的现有知识。由国际移植研究协会(IRTA)牵头、寺崎研究所管理的ITR每年收集数据,并利用这些数据生成指导管理策略和政策声明的报告。本手稿的目的是分析小儿肠道移植的特定结果。分析了1985年至2017年接受移植儿童的结果数据,并评估了预测因素。在此期间,共有2010名儿童接受了2080例含肠道的同种异体移植物。总体而言,1年和5年的患者及移植物存活率分别为72.7%/66.1%和57.2%/48.8%。1年条件存活率与首次移植受者和含肝脏移植物最为相关。与住院状态相比,患者存活率与移植的择期状态最为相关。随着时间的推移,移植后的肠道自主性持续改善,包含结肠的移植在肠道自主性和摆脱静脉输液方面显示出额外的渐进性改善。虽然与早期相比,移植后淋巴细胞增生性疾病(PTLD)和技术并发症对移植物丢失的影响较小,但排斥反应仍然是长期移植物丢失的最大原因。再次移植与条件性移植物存活率显著降低有关,败血症仍然是患者死亡的最大原因。新的数据元素聚焦于供体变量的影响、供体和受体组织配型以及新生抗体产生的影响。